Lindbrook Capital, LLC Intellia Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

  • $1.18 Billion
  • Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 87 shares of NTLA stock, worth $1,226. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87
Previous 263 66.92%
Holding current value
$1,226
Previous $5,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$19.72 - $27.36 $3,470 - $4,815
-176 Reduced 66.92%
87 $1,000
Q2 2024

Jul 31, 2024
SELL
$20.02 - $27.22 $5,665 - $7,703
-283 Reduced 51.83%
263 $5,000
Q1 2024

Apr 25, 2024
SELL
$23.82 - $32.8 $1,405 - $1,935
-59 Reduced 9.75%
546 $15,000
Q4 2023

Jan 31, 2024
BUY
$23.16 - $32.34 $8,800 - $12,289
380 Added 168.89%
605 $18,000
Q3 2023

Oct 25, 2023
BUY
$31.62 - $45.78 $1,517 - $2,197
48 Added 27.12%
225 $7,000
Q2 2023

Jul 28, 2023
BUY
$34.58 - $46.03 $3,181 - $4,234
92 Added 108.24%
177 $7,000
Q1 2023

Apr 26, 2023
SELL
$33.3 - $44.82 $1,032 - $1,389
-31 Reduced 26.72%
85 $3,000
Q4 2022

Jan 24, 2023
SELL
$33.21 - $62.69 $4,084 - $7,710
-123 Reduced 51.46%
116 $0
Q3 2022

Nov 10, 2022
BUY
$53.92 - $71.7 $1,132 - $1,505
21 Added 9.63%
239 $13,000
Q2 2022

Aug 01, 2022
SELL
$38.49 - $76.21 $461 - $914
-12 Reduced 5.22%
218 $11,000
Q1 2022

Apr 21, 2022
SELL
$58.27 - $118.99 $21,559 - $44,026
-370 Reduced 61.67%
230 $17,000
Q4 2021

Jan 18, 2022
BUY
$100.76 - $138.36 $55,619 - $76,374
552 Added 1150.0%
600 $71,000
Q2 2021

Jul 27, 2021
SELL
$60.88 - $161.91 $5,905 - $15,705
-97 Reduced 66.9%
48 $8,000
Q1 2021

Apr 28, 2021
BUY
$46.59 - $83.68 $6,755 - $12,133
145 New
145 $12,000
Q3 2020

Nov 03, 2020
SELL
$17.47 - $24.93 $3,266 - $4,661
-187 Closed
0 $0
Q2 2020

Jul 27, 2020
BUY
$11.14 - $22.87 $2,083 - $4,276
187 New
187 $4,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.07B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email